- Home
- ACT vs PTCT Comparison
ACT vs PTCT Comparison
Compare ACT & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ACT | PTCT |
|---|---|---|
| Founded | 1981 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 5.7B |
| IPO Year | 2021 | 2006 |
Fundamental Metrics
Financial Performance| Metric | ACT | PTCT |
|---|---|---|
| Price | $42.47 | $78.88 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 17 |
| Target Price | $44.25 | ★ $80.65 |
| AVG Volume (30 Days) | 258.4K | ★ 1.5M |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.90% | N/A |
| EPS Growth | 3.43 | ★ 264.48 |
| EPS | ★ 1.18 | N/A |
| Revenue | ★ $1,235,827,000.00 | $264,734,000.00 |
| Revenue This Year | $4.06 | N/A |
| Revenue Next Year | $2.33 | $17.70 |
| P/E Ratio | $35.83 | ★ N/A |
| Revenue Growth | 2.83 | ★ 36.19 |
| 52 Week Low | $33.94 | $43.18 |
| 52 Week High | $44.80 | $87.50 |
Technical Indicators
Market Signals| Indicator | ACT | PTCT |
|---|---|---|
| Relative Strength Index (RSI) | 50.68 | 63.72 |
| Support Level | $41.98 | $73.41 |
| Resistance Level | $42.80 | $79.67 |
| Average True Range (ATR) | 0.83 | 3.08 |
| MACD | 0.13 | 0.69 |
| Stochastic Oscillator | 72.83 | 91.83 |
Price Performance
Historical ComparisonAbout ACT Enact Holdings Inc.
Enact Holdings Inc is a private mortgage insurance company serving the United States housing finance market. The company operates in a single reportable segment namely Mortgage Insurance The principal mortgage insurance customers are originators of residential mortgage loans that determines the mortgage insurer or insurers to be used for the placement of mortgage insurance written on loans originated. The company is engaged in writing and assuming residential mortgage guaranty insurance.
About PTCT PTC Therapeutics Inc.
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.